Brief communication| Volume 40, ISSUE 6, P863-867, December 15, 1985

The characterization of a panel of monoclonal antibodies to human coagulation factor IX

      This paper is only available as a PDF. To read, Please Download here.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Esnouf M.P.
        Biochemistry of blood coagulation.
        in: Thomas D. In, British Medical Bulletin. 1977: 213-218 (33)
        • Bloom A.L.
        in: Bloom A.L. In, The Haemophiliacs. Churchill and Livingstone, Edinburgh1982: 1-17
        • Smith K.J.
        • Ono K.
        Monoclonal antibodies to factor IX: Characterization and use in immunoassay for factor IX.
        Thromb. Res. 1984; 33: 221-224
        • Thompson A.
        Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three haemophilia-B patients.
        Blood. 1983; 62: 1027-1034
        • Yoshioka A.
        • Giddings J.C.
        • Thomas J.E.
        • Fujumura Y.
        • Bloom A.L.
        Immunoassay of factor IX antigen using monoclonal antibodies.
        Br. J. Haemat. 1985; 59: 265-275
        • Usharani P.
        • Warn-Cramer B.J.
        • Kasper C.K.
        • Bajaj S.P.
        Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach and Los Angeles) of haemophilia-B.
        J. Clin. Invest. 1985; 75: 76-83
        • Bajaj P.
        • Rapaport S.I.
        • Maki S.L.
        A monoclonal antibody to factor IX which inhibits the factor VIII Ca potentiation of factor X activation.
        Circulation. 1984; 70 (abstract 797)
        • Goodall A.H.
        • Kemble L.
        • O'Brien D.P.
        • Rawlings E.
        • Rotblat F.
        • Russeli G.C.
        • Janossy G.
        • Tuddenham G.D.
        Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody.
        Blood. 1982; 59: 640-670
        • Gurtler L.G.
        • Wernicke D.
        • Eberle J.
        • Zoulek G.
        • Deinhardt F.
        • Schramm W.
        Increase in prevalance of anti-HTLV-III in haemophiliacs.
        Lancet. 1984; ii: 1275-1276
        • Wright J.F.
        • Hunter W.M.
        A convenient replacement for cyanogen bromide activated solid phase in immunoradiometric assays.
        J. Immunol. Methods. 1982; 43: 311-325
        • Kohler G.
        • Howe S.C.
        • Milstein C.
        Fusion between immunoglobulin secreting and nonsecreting myeloma cell lines.
        Eur. J. Immunology. 1976; 6: p 292
        • Clark M.R.
        • Wright B.W.
        • Milstein C.
        Unpublished results quoted by Galfre, G., and, Milstein, C.
        Methods in Enzymology. 1981; 73 (part B)
        • Kennet R.H.
        • Denis K.A.
        • Tung A.S.
        • Klinman N.R.
        Hybrid plasmacytoma production: Fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells.
        Current Topics In Microbiology and Immunology. 1978; 81: 77-91
        • Oi V.T.
        • Herzenberg L.A.
        Immunoglobulin producing hybrid cell lines.
        in: Mishell B.B. Shiigi S.M. Selected Methods in Cellular Immunology. W.H. Freeman and Co, San Francisco1980: 351-372
        • Hunter W.M.
        • Greenwood F.C.
        Preparation of iodine-Labelled human growth hormone of high specific activity.
        Nature. 1962; 194: 495-496
        • Dawes J.
        • James K.
        • Micklem L.R.
        • Pepper D.S.
        • Prowse C.V.
        Monoclonal antibodies directed against human thrombin and the thrombin-antithrombin III complex.
        Thromb. Res. 1984; 36: 397-409
        • Ey P.L.
        • Prowse S.J.
        • Jenkin C.R.
        Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-Sepharose.
        Immunochemistry. 1978; 15: 429-436
        • Laemmli U.K.
        Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
        Nature. 1970; 227: 680-685
        • Lewis R.M.
        • Reisner H.M.
        • Chung K.S.
        • Roberts H.R.
        Detection of factor IX antibodies by radioimmunoassay:Effect of calcium on antibody factor IX interaction.
        Blood. 1980; 56: 608-614
        • Morita T.
        • Isaacs B.S.
        • Esmon C.T.
        • Johnson A.E
        Derivatives of blood coagulation factor IX contain a high affinity Ca2+ binding site that lacks carboxy-glutamic acid.
        J. Biol. Chemistry. 1984; 259: 5698-5704
        • Discipio R.G.
        • Kurachi K.
        • Davie E.W.
        Activation of human factor IX (Christmas Factor).
        J. Clin. Invest. 1978; 61: 1528-1538